Update from my previous post: $RMTI held a conference call with HC Wainwright, quantifying the opportunity for the large contract to be announced within 2 weeks. This would be to the tune of $90-94m in annual revenues, highly likely to come from Fresenius outsourcing the production of their low operating margin concentrate business. This would get $RMTI to $154m annual revenues by 2025 (street is only estimating ~$79m). On a 1.4x sales multiple this would mean a $6.86 price target, with 186% upside. I previously only assumed a $15m contract out of conservatism, but probability seems skewed towards a much larger contract than anyone currently expects. Guidance upgrades are incoming, market has not priced in any probability of new contracts at all.

See full calculation here: https://x.com/ForensicGains/status/1858542721419407378